Jane Chung

Jane Chung is an accomplished biotechnology executive with more than two decades of experience in pharmaceutical commercialization, strategy, and leadership. She currently serves as Chief Executive Officer and board member at Sutro Biopharma, Inc. [STRO], a clinical-stage company focused on developing next-generation oncology therapeutics. Chung has held multiple senior roles at global pharmaceutical firms, including leadership positions at AstraZeneca, Genentech, Inc., and Onyx Pharmaceuticals. Known for her expertise in oncology markets and commercialization strategies, she has played a key role in advancing therapies from development to market. Her leadership combines scientific understanding with strategic business execution, positioning her as a prominent figure in the biotech sector.